abrdn Life Sciences Investors (HQL) is a publicly traded Financial Services sector company. As of May 21, 2026, HQL trades at $17.23 with a market cap of $537.31M and a P/E ratio of 0.00. HQL moved +1.41% today. Year to date, HQL is +6.90%; over the trailing twelve months it is +38.84%. Its 52-week range spans $10.55 to $18.46. Rallies surfaces HQL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
HQL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HQL recently traded at $17.23. Market cap is $537.31M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $17.23 |
| Market Cap | $537.31M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.56% |
| 52-Week High | $18.46 |
| 52-Week Low | $10.55 |
| Volume | 208 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
HQL analyst coverage data. Average price target: $0.00.